Connect your AI

LivaNova LIVN Operating Cash Flow

Operating Cash Flow at other companies

AbbottABT

$1.32B-7.2%

HaemoneticsHAE

$70.94M-39.1%

MedtronicMDT

$2.57B+1.8%

ResMedRMD

$554.13M-4.2%

Boston ScientificBSX

$348M-35.7%

StrykerSYK

$581M+132%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.31B+62.8%

Enterprise value$4.11B+58.0%

P/S3×+0.9×

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's operating cash flow?: LivaNova (LIVN) reported operating cash flow of $15.22M in Q1 2026.
How has LivaNova's operating cash flow changed year-over-year?: LivaNova's operating cash flow decreased by 36.5% year-over-year, from $23.97M to $15.22M.
What is the long-term trend for LivaNova's operating cash flow?: Over 2 years (2021 to 2025), LivaNova's operating cash flow has grown at a 57.5% compound annual growth rate (CAGR), from $102.54M to $254.34M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.